Project 4's objective is to characterize transcriptional and epigenetic mechanisms underlying heroin abuse in humans, with complementary, mechanistic studies in rodents. We focus on two key brain reward regions, nucleus accumbens (NAc) and prefrontal cortex (PFC), and concentrate on dysregulation of genes related to glutamatergic neurotransmission, a major focus of Projects 1 and 2. By studying human brain, the proposed studies fill a major gap in the field. Preliminary data from a microarray analysis have already demonstrated abnormal expression of several glutamate-related genes in NAc of human heroin abusers. We will validate and extend these findings by obtaining a more comprehensive view of gene expression in NAc by use of RNA-Seq in conjunction with the Chromatin and Gene Analysis Core, and will study the PFC as well. Specific glutamate-related genes will be further analyzed with respect to the neuronal cell types that show abnormal expression within these regions of human brain using laser capture microdissection. To interrogate the molecular mechanisms underlying these heroin-induced molecular changes, we will perform parallel studies in rats that self-administer heroin over an extended time period, and utilize viral gene transfer to evaluate causal relationships between specific gene targets and heroin seeking and taking. These studies of gene expression will then be extended further to the epigenetic level to gain unique insight into the underlying mechanisms involved. ChlP-Seq will be conducted, again with the Core, to map genome-wide binding of a select number of chromatin modifications and transcription factors in the human NAc and PFC. For example, we will initially explore H3K9me2 (dimethylation of Lys9 of histone H3) and the transcription factor CREB, given the wealth of evidence from Projects 1 and 3 for their involvement in drug addiction. We will use advanced bioinformatics to align our data from human and rodent models and characterize biochemical pathways that display dysregulation. Overall, the novel research in this Project, which is fully integrated with the other Projects and Cores, will provide a crucial translational dimension to our overall program of research, and help advance molecular knowledge about the pathophysiology of drug addiction.

Public Health Relevance

Addiction remains one of the world's greatest public health problems, yet its pathophysiology remains incompletely understood and available treatments for addictions to various drugs of abuse are inadequately effective for most people. We believe that the most effective way of eventually developing definitive treatments and cures for addiction rests in part in a better understanding of its underlying neurobiology.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
2P01DA008227-22A1
Application #
8609277
Study Section
Special Emphasis Panel (ZRG1-IFCN-B (40))
Project Start
Project End
Budget Start
2014-01-01
Budget End
2014-12-31
Support Year
22
Fiscal Year
2014
Total Cost
$228,827
Indirect Cost
$93,826
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Cates, Hannah M; Li, Xuan; Purushothaman, Immanuel et al. (2018) Genome-wide transcriptional profiling of central amygdala and orbitofrontal cortex during incubation of methamphetamine craving. Neuropsychopharmacology 43:2426-2434
Gaspari, Sevasti; Purushothaman, Immanuel; Cogliani, Valeria et al. (2018) Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/?-catenin pathway. Proc Natl Acad Sci U S A 115:E2085-E2094
Miller, M L; Ren, Y; Szutorisz, H et al. (2018) Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability. Mol Psychiatry 23:1328-1335
Monteggia, Lisa M; Heimer, Hakon; Nestler, Eric J (2018) Meeting Report: Can We Make Animal Models of Human Mental Illness? Biol Psychiatry 84:542-545
Clark, Christopher R; Maile, Makayla; Blaney, Patrick et al. (2018) Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene. Sci Rep 8:15327
Cates, Hannah M; Heller, Elizabeth A; Lardner, Casey K et al. (2018) Transcription Factor E2F3a in Nucleus Accumbens Affects Cocaine Action via Transcription and Alternative Splicing. Biol Psychiatry 84:167-179
Cahill, M E; Walker, D M; Gancarz, A M et al. (2018) The dendritic spine morphogenic effects of repeated cocaine use occur through the regulation of serum response factor signaling. Mol Psychiatry 23:1474-1486
Hamilton, Peter J; Burek, Dominika J; Lombroso, Sonia I et al. (2018) Cell-Type-Specific Epigenetic Editing at the Fosb Gene Controls Susceptibility to Social Defeat Stress. Neuropsychopharmacology 43:272-284
Egervari, Gabor; Kozlenkov, Alexey; Dracheva, Stella et al. (2018) Molecular windows into the human brain for psychiatric disorders. Mol Psychiatry :
de la Fuente Revenga, Mario; Ibi, Daisuke; Saunders, Justin M et al. (2018) HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice. Neuroscience 388:102-117

Showing the most recent 10 out of 312 publications